...
首页> 外文期刊>Lipids in Health Disease >CETP gene polymorphisms and risk of coronary atherosclerosis in a Chinese population
【24h】

CETP gene polymorphisms and risk of coronary atherosclerosis in a Chinese population

机译:CETP基因多态性与中国人群冠状动脉粥样硬化的风险

获取原文

摘要

Background Coronary atherosclerosis, the most common form of coronary artery disease (CAD), is characterized by accumulation of lipid in the walls of coronary arteries. Recent data from clinical trials have showed that high-density lipoprotein cholesterol (HDL-C) has causal role in the pathogenesis and development of coronary atherosclerosis. Cholesteryl ester transfer protein (CETP) is an important regulator of plasma HDL-C. Several genetic mutations in the CETP gene were found to be associated with HDL-C levels. The aim of the present study is to evaluate the association of HDL-C-related CETP polymorphisms and risk of coronary atherosclerosis. Methods We investigated the association of seven single nucleotide polymorphisms (SNP) (rs1800775, rs708272, rs5882, rs1532624, rs1864163, rs7499892, and rs9989419) in the CETP gene with the risk of coronary atherosclerosis and levels of HDL-C in a case–control study in China. Included in the study were 420 patients with coronary atherosclerosis and 424 healthy controls. SNP genotyping was performed by TaqMan allelic discrimination assay and serum lipid levels were measured by standard laboratory methods. Results Carriers of the AA and GA?+?AA genotypes of rs708272 had significant lower risks of coronary atherosclerosis (OR?=?0.55, 95% CI: 0.36-0.85, p?=?0.003; OR?=?0.67, 95% CI: 0.50-0.90, p?=?0.007, respectively) compared to those with GG genotype. These relations remained significant after adjustment for confounding effects of age, smoking, diabetes and hypertension. The rs1800775 polymorphism was significantly associated with serum levels of HDL-C in healthy controls (p?=?0.04). Besides, rs708272 was in close linkage disequilibrium (LD) with rs1800775 in this study. Conclusions Our findings indicated that CETP rs708272 may be associated with the risk of coronary atherosclerosis and rs1800775 may influence serum HDL-C levels in healthy controls in Chinese.
机译:背景技术冠状动脉粥样硬化是冠状动脉疾病(CAD)的最常见形式,其特征是脂质在冠状动脉壁中积聚。来自临床试验的最新数据表明,高密度脂蛋白胆固醇(HDL-C)在冠状动脉粥样硬化的发病和发展中具有因果作用。胆固醇酯转移蛋白(CETP)是血浆HDL-C的重要调节剂。发现CETP基因中的一些遗传突变与HDL-C水平有关。本研究的目的是评估HDL-C相关的CETP多态性与冠状动脉粥样硬化风险的关系。方法我们调查了CETP基因中的七个单核苷酸多态性(SNP)(rs1800775,rs708272,rs5882,rs1532624,rs1864163,rs7499892和rs9989419)与冠心病患者的冠状动脉粥样硬化风险和HDL​​-C水平的相关性在中国学习。该研究包括420例冠状动脉粥样硬化患者和424例健康对照者。通过TaqMan等位基因鉴别分析进行SNP基因分型,并通过标准实验室方法测量血清脂质水平。结果rs708272的AA和GA?+?AA基因型携带者患冠状动脉粥样硬化的风险显着降低(OR?=?0.55,95%CI:0.36-0.85,p?=?0.003; OR?=?0.67,95%与具有GG基因型的那些相比,CI:0.50-0.90,p≤= 0.007)。在调整了年龄,吸烟,糖尿病和高血压的混杂影响后,这些关系仍然很重要。 rs1800775多态性与健康对照者的血清HDL-C水平显着相关(p≤0.04)。此外,在本研究中,rs708272与rs1800775存在紧密连锁不平衡(LD)。结论我们的发现表明,CETP rs708272可能与冠状动脉粥样硬化的风险有关,而rs1800775可能影响中国健康对照者的血清HDL-C水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号